A 78-year-old man with cardiac amyloidosis developed sinus bradycardia with symptomatic hypotension. Three months after receiving an advanced biventricular pacemaker system with continuous accelerated rate pacing (daytime: 70 beats/min; nighttime: 90 beats/min), his health status and symptoms were markedly improved.
View Article and Find Full Text PDFBackground: Patients have substantial variability in perioperative outcomes after left ventricular assist device (LVAD) implant. A perioperative multidimensional tool integrating mortality, adverse events (AEs), and patient-reported outcomes to assist in quality improvement initiatives is needed.
Methods: Patients undergoing HeartMate 3 LVAD implant (January 1, 2017 to January 31, 2024) in the Society of Thoracic Surgeons' Intermacs registry were studied.